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Objectives. This study sought o determine whether in-hospital 
and intermediate-term posthospital outcomes have changed in 
elderly patients undergoing percutaneous transluminal coronary 
angioplasty from the period 1980 through 1989 to the period 1990 
through 1992. 
Background. Although elderly patients have a higher incidence 
of procedure-related deaths and late recurrence of angina after 
coronary angioplasty, recent complication rates for angioplasty 
seem to be lower. 
Methods. From 1980 to 1989, 982 patients _>65 years old 
underwent nonemergent coronary angioplasty (group A). They 
were compared with 768 similar patients who had coronary 
angioplasty from 1990 to 1992 (group B). 
Results. Patients in group B were older than those in group A 
and had a higher mean concomitant disease score, a higher 
proportion of men and a greater proportion of patients with a 
previous myocardial infarction and previous coronary artery 
bypass urgery. Despite the increased complexity of the group B 
cohort, procedural success rates were higher, and rates of impor- 
tant in-hospital complications were much lower than those in 
group A. For group A versus group B, respectively, the technical 
success rate was 88.1% versus 93.5% (p < 0.001), in-hospital 
death rate 3.3% versus 1.4% (p = 0.014), emergency bypass 
surgery rate 5.5% versus 0.65% (p < 0.001) and incidence of 
in-hospital death or myocardial infarction 6.3% versus 3.4% (p < 
0.005). However, intermediate-term posthospital event-free rates 
in hospital survivors did not decrease. The rate of death or 
myocardial infarction at 6 months was 4.7% in group A versus 
7.1% in group B (p < 0.05). Survival free of acute myocardial 
infarction, bypass urgery, repeat coronary angioplasty or severe 
angina at 1 year was 66.7% in group A versus 54.9% in group B (p 
< 0.001). The combined in-hospital death/myocardial nfarction 
rate plus that for the first 6 months after hospital dismissal was 
essentially equivalent for the two groups (10.3% vs. 9.9%, p = NS). 
Conclusions. An increase in technical success rates and a 
reduction in short-term complication rates for coronary angio- 
plasty in the elderly in recent years have not translated into an 
improved event-free survival rate, which continues to be influ- 
enced by important baseline characteristics of these high risk 
patients. 
(J Am Coil Cardiol 1996;27:8-14) 
Numerous reports (1-10) have emphasized that elderly pa- 
tients have a higher incidence of procedure-related death and 
late recurrence of angina after percutaneous transluminal 
coronary angioplasty. However, recent complication rates for 
this procedure seem to have decreased as operator experience 
has continued to grow, new technology has become available 
and practice patterns have been modified. The present study 
was designed to determine whether early and intermediate- 
term outcomes have changed in this high risk group of patients 
from the period 1980 through 1989 to the more recent 
experience of 1990 through 1992. 
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Methods  
Study patients. The study included 1,750 elderly patients 
who underwent conventional coronary angioplasty at the Mayo 
Clinic between April 30, 1980 and December 31, 1992. The 
method of prospective data registry (1), patient characteristics 
and statistical predictors of outcome for the 982 patients 
undergoing coronary angioplasty between April 1, 1980 and 
January 5, 1990 have been reported elsewhere (11). This well 
studied group of 982 patients (group A) was compared with a 
recent group of 768 similarly defined patients ->65 years old 
who underwent coronary angioplasty between January 6, 1990 
and December 31, 1992 (group B). Fifty-eight elderly patients 
(41 in group A, 17 in group B) whose only procedure was an 
unsuccessful attempt to dilate a 100% occluded coronary 
artery were excluded. The minimal follow-up period was 6 
months (mean [+SD] 58 _+ 25 [group A], 17 _+ 10 [group B]) 
and was obtained for 100% of patients. 
Definitions. Baseline characteristics (e.g., unstable angina 
pectoris, congestive heart failure and concomitant disease 
score) and in-hospital and late events (e.g., successful coronary 
artery dilation and recurrent angina) have been previously 
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Table 1. BaseLine Characteristics of Study Groups 
Group A Group B 
(1980-1989; (1990-1992; 
n = 982) n = 768) 
P 
Value 
Men (%) 
Mean (+SD) age (yr) 
CCS angina class (%) 
1/II 
III/IV 
V* 
No angina 
Cardiac/medical (%) 
Unstable angina 
Previous CHF 
Current CHF 
Any previous MI 
Multiple previous MI 
Previous CABG 
Previous HTN 
LVEF 
Current smoker 
Diabetes mellitus 
Mean (+SD) concomitant 
disease scorer 
61.6 69.0 0.001 
72.4 _+ 5.4 73.5 + 5.7 < 0.001 
14.8 13.5 
62.8 62.5 
17.7 19.3 
4.7 4.8 
NS 
72.5 74.5 NS 
14.1 13.8 NS 
9.1 8.0 NS 
46.8 51.6 0.05 
10.3 11.6 NS 
14.6 21.4 < 0.001 
55.3 55,0 NS 
61.5 64.4 < 0.001 
(n - 834) (n - 704) 
10.2 8.9 N8 
15.7 19.8 < 0.05 
1.13 _+ 1.06 1.23 _+ 1.11 < 0.05 
*Angina only at rest (no exertional pain). +See reference 11. CABG = 
coronary artery bypass graft surgery.; CCS = Canadian Cardiovascular Society,; 
CHF - congestive heart failure; HTN = hypertension; LVEF = left ventricular 
ejection fraction; MI = myocardial infarction. 
defined (1,4,11). Successful coronary angioplasty = 40% reduc- 
tion in diameter stenosis without major complications. In- 
hospital myocardial infarction = development of new patho- 
logic Q waves or ST segment changes and either prolonged 
chest pain or change in cardiac enzyme levels. Myocardial 
infarction after hospital dismissal = either new pathologic Q 
waves or an abnormal increase in cardiac isoenzyme levels in 
the setting of typical chest pain or changes in electrocardio- 
graphic repolarization pattern. Complete revascularization = no 
residual stenosis ->70% by visual inspection in the left main, 
right, anterior descending or circumflex coronary arteries or 
their major branches, unless a bypass graft free of significant 
disease subtended the territory distal to the diseased segment. 
The coronary angioplasty approach was consistent with 
contemporary practices at the time of the angioplasty proce- 
dure (5,12). Steerable balloons, autoperfusion balloons (13,14) 
and adjustment of heparin dosage by measurement of acti- 
vated clotting times (15,16) were used as they became available 
during the course of the study. 
Statistical methods. Baseline variables, complications and 
success rates were compared between time periods using the 
Pearson chi-square test for discrete variables or the Student t 
test for continuous variables. For each time period, compari- 
sons were made between the three age groups with either the 
Pearson chi-square test or analysis of variance to test for 
overall group differences. The log-rank test was used to test for 
group differences between the Kaplan-Meier curves of event- 
free survival. 
The logistic regression model developed from patients in 
group A and presented previously (11) (Appendix 1) was used 
to calculate an expected probability of an event for each 
patient in group B. These probabilities were ordered and 
divided into quintiles of approximately equal size. The proba- 
bilities within each quintile were summed to calculate the 
expected event rate for each quintile. These rates were com- 
pared with the actual number of events in each quintile. 
With the Cox models and data from group A, expected 
event-free curves and relative risk ratios were calculated for 
patients in group B (Appendix 2). Patients in group B were 
Table 2. Baseline Data by Age 
Group A 
65-69 yr 70-74 yr ->75 yr 
(n = 400) (n = 300) (n = 282) 
Group B 
65-69 yr 70-74 yr ->75 yr 
p Value (n = 257) (n = 241) (n = 270) p Value 
Men (%) 67.5 58.7 56.4 
Mean (+SD) age (yr) 67.5 + 1.4 72.4 +_ 1.4 79.5 = 3.7 
CCS angina class (%) 
i/Ii 19.0 16.4 7.3 
Ill/1V 59.2 63.4 67.6 
V* 17.1 15.3 21.0 
No angina 4.7 5.0 4.2 
Cardiac/medical (%) 
Unstable angina 69.0 73.3 76.6 
Previous CHF 9.6 9.7 25.3 
Current CHF 5.3 5.4 18.6 
Any previous MI 42.0 47.0 53.6 
Multiple previous MI 6.8 9.7 16.0 
Previous CABG 15.0 14.3 14.2 
Previous HTN 53.4 56.5 56.5 
0.006 72.0 75.5 60.4 < 0.001 
67.7 _+ 1.5 72.4 _+ 1.5 79.9 +_ 3.7 
21.7 11.7 7.3 
0.003 54.9 59.6 72.2 < 0.001 
17.5 22.4 18.2 
6.0 6.3 2.4 
0.09 71.2 74.3 77.8 NS 
< 0.001 11.3 13.9 16.0 NS 
< 0.001 6.7 8.0 9.3 NS 
0.01 47.7 55.5 51.9 NS 
< 0.001 10.9 10.1 13.4 NS 
0.95 22.2 22.0 20.0 NS 
0.65 52.6 52.5 59.6 NS 
*Angina only at rest (no exertional pain). Abbreviations as in Table 1. 
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Table 3. Comparison fAngiographic Outcome 
Group A Group B 
(1980-1989; (1990-1992; p 
n 982) n = 768) Value 
No. of segments 1,421 1,097 
No. of vessels dilated (%) 
1 80.7 83.1 
2 18.1 16.4 
3 1.2 0.52 
Success rate/segment (%) 86.4 92.0 
Success rate/patient (%) 88.1 93.5 
No. of grafts attempted 69 87 
0.19 
<0.001 
< 0.001 
0.007 
Table 5. Comparison ofAcute Complication Rates 
Group A Group B 
(1980-1989; (1990-1992; 
n - 982) n = 768) 
[no. (%) of [no. (%) of 
pts] pts] 
P 
Value 
MI 38 (3.9) 17 (2.2) 0.049 
Ventricular arrhythmia 38 {3.9) 2() (2.6) 0.14 
Abrupt coronary artery occlusion 67 (6.8) 25 (3.3) 0.001 
CABG within 24 h 54 (5.5) 5 (0.65) < 0.001 
Death 32 (3.3) 11 (1.4) 0.014 
Death or M1 62 (6.3) 26 (3.4) 0.005 
pts = patients; other abbreviations a in Table 1. 
sorted by these risk ratios and divided into five groups on the 
basis of quintiles from the previous tudy (11). The expected 
event-free curves within each group were averaged to obtain 
expected event-free curves for each of the quintiles. Kaplan- 
Meier curves were computed for each of the five groups to 
obtain curves of the observed events. This method was re- 
peated to calculate the observed and expected curves tratified 
by age group. 
Resu l ts  
Clinical and baseline cardiovascular characteristics of pa- 
tients in groups A and B are shown in Table 1. The incidence 
of unstable angina was high in both groups. Group B had a 
higher proportion of men, and the patients were older and had 
more complex heart disease (with a higher incidence of 
previous myocardial infarction and bypass surgery) and a 
slightly higher score of concomitant diseases (p < 0.05). The 
proportion of patients with complete revascularization was 
52.2% in group A and 51.7% in group B (p = NS). 
Table 2 documents he baseline characteristics according to 
age groups. The oldest patient subgroup (->75 years) had a 
higher incidence of severe angina in both groups A and B. 
Procedural and in-hospital outcome. There was no signif- 
icant difference in number of vessels or number of segments 
dilated, which averaged 1.21 and 1.45/patient in group A and 
1.17 and 1.43/patient in group B. However, the procedural 
success rate was significantly higher in group B than in group 
A and averaged 93.5% (Table 3). Table 4 shows the success 
rate by age groups. In group B, the procedural success rate was 
>91% in each age group and did not differ among groups. 
Important procedural complications were also substantially 
less common in the elderly in more recent years. The incidence 
of acute coronary artery occlusion, emergency bypass urgery 
and procedural mortality was significantly lower in group B 
(Table 5). Most striking, bypass surgery immediately after 
coronary angioplasty occurred in only 0.65% of patients from 
1990 to 1992, compared with 5.5% in previous years. The 
in-hospital death rate also decreased from 3.3% to 1.4%. 
Intravascular stents were introduced into the cardiac labo- 
ratory in late 1989. During the course of the study, no patient 
was excluded from group A because of stent placement, 
whereas 37 patients were excluded from group B because of 
nonelective stent placement. The reason for stent placement 
was coronary artery dissection in 26 patients, abrupt coronary 
artery closure in 6, suboptimal dilation in 4 and high risk 
coronary angioplasty lesion in 1. Of these 37 patients, 2 died, 
and 6 had a myocardial infarction. Because many patients in 
this group would have been referred for urgent coronary 
bypass operation i  the prestent era, the use of stents appears 
to be a major contributor to the decrease in the rate of 
emergency bypass operation. Of the patients in groups A and 
Table 4. Comparison ofAngiographic Outcome by Age 
Group A 
65-69 yr 70-74 yr >75 yr 
(n - 400) (n = 300) (n = 282) 
Group B 
p 65-69 yr 70-74 yr ~75 yr p 
Value (n 257) (n 241) (n 270) Value 
No. of segments 578 422 421 
No. of vessels dilated (%) 
1 81.8 84.3 75.2 
2 17.3 14.3 23.4 
3 1.0 1.3 1.4 
Success rate/segment (%) 84.6 86.5 88.8 
Success rate/patient (%) 87.3 88.0 89.4 
No. of grafts attempted 29 22 18 
366 339 392 
81.3 85.5 82.6 
0.07 17.9 14.5 16.7 0.56 
(I.8 0.0 0.7 
0.16 93.7 91.5 90.8 (t.31 
0.7 95.7 93.0 91.9 0.18 
0.98 32 26 29 0.9l 
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Table 6. Expected Event Rates for In-Hospital Death or Myocardial 
Infarction From Previous Analysis Applied to Newer Patient Cohort 
(group B) 
No. of Events 
Risk No. of 
Quintile Patients Observed Expected 
1 153 1 3.80 
2 154 1 5.4l 
3 153 5 7.51 
4 154 6 11.35 
5 154 13 25.98 
Total 768 26 54.05 
B, 54.3% and 67.1%, respectively, were receiving heparin 
intravenously before coronary angioplasty (p < 0.001), and 
4.2% and 9.4%, respectively, were taking warfarin after coro- 
nary angioplasty (p = NS). 
Table 6 lists the expected event rates of in-hospital death or 
myocardial infarction derived from the previous analysis (11) 
and applied to the newer patient cohort. By using the previ- 
ously defined model that incorporated the number of 70% 
lesions and age as risk factors (Appendix 1), the actual event 
rates of in-hospital death and myocardial infarction were 
substantially ower in the more recent cohort than expected, 
when these patient characteristics were considered. However, 
the previously defined formula for risk stratification appeared 
to stratify risk similarly within group B in that there was a 
gradual increase in risk, from 2% to 16% in the first and fifth 
quintiles, respectively. 
Posthospital results. The mean (_+SD) follow-up period 
was 58 _+ 25 months for group A and 17 _+ 10 months for group 
B. Survival for both groups was high despite the advanced age 
and level of illness in both groups (Fig. 1). Although survival 
after hospital dismissal was slightly better in group A, this 
difference was not statistically significant. Also, there was no 
difference between the two groups in noncardiac death after 
hospital dismissal. 
For the combined end point of death and myocardial 
infarction in hospital survivors, the event rate was slightly 
higher in group B. This is shown for each age group of the 
elderly in Figure 2. Figure 3 shows Kaplan-Meier curves of 
survival free of myocardial infarction based on quintiles of risk 
that were previously defined in group A. Although the risk 
stratification based on the model developed for the patients in 
group A continued to effectively stratify the more recent 
cohort, the event rates were higher in each risk quintile of the 
recent cohort. Thus, despite correcting for known risk factors 
in this way, the event rate was still higher than expected in 
group B. 
The combined hospital death or myocardial infarction rate 
plus death or myocardial infarction in the first 6 mo after 
hospital dismissal was essentially equivalent for the two groups 
(10.3% for group A; 9.9% for group B, p = NS). 
Kaplan-Meier curves of survival free of myocardial infarc- 
tion, severe angina, repeat coronary angioplasty and bypass 
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Figure 1. Kaplan-Meier curves of survival after hospital dismissal for 
group A (1980 to 1989) and group B (1990 to 1992). The overall 
survival rate was high for both groups. 
surgery after hospital dismissal are shown in Figures 4 and 5. 
Figure 4 shows curves of overall event-free survival for the 
three age groups compared with expected results from the 
previous experience. In each age group, event-free survival 
rates were lower in group B. Figure 5 shows overall event-free 
survival rate for group B compared with expected results by 
risk quintile. Again, although the expected event-free curve 
derived from the models from group A patients and applied to 
the recent cohort appropriately stratify the event risk in group 
B, the event-free survival rates were lower for each of the five 
quintiles. 
Discuss ion  
Several investigators have shown (1-10) that the mortality 
rate and risk of other acute complications after angioplasty are 
higher in elderly than in younger patients. The present study 
demonstrates that the technical success rate has been signifi- 
cantly higher and the acute complication rate substantially 
lower in the elderly since 1990 than the earlier experience at 
our institution. Several technical advances have undoubtedly 
contributed to the improved outcome, including use of perfu- 
sion balloons for high risk lesions and abrupt closure 
(13,14,17), long balloons for diffusely diseased segments 
(18,19), frequent monitoring of anticoagulation status in the 
cardiac catheterization laboratory (15,16) and numerous im- 
provements in balloon technology. The use of intracoronary 
artery stents for coronary angioplasty especially appears to 
have had a major impact on the incidence of emergency 
coronary bypass operations. All these advances have had a 
favorable impact on the technical success rates of coronary 
angioplasty inrecent years. Also, operator experience with this 
procedure has continued to improve. Furthermore, very high 
risk lesions may have been treated with nonballoon techniques. 
Even with these explanations for improvement in technical 
success rate, the magnitude of the improvement in this high 
risk group of patients is still striking. For example, we found 
that the in-hospital mortality rate in these patients decreased 
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Figure 2. Comparison of the ob- 
served Kaplan-Meier curves for 
survival free of myocardial infarc- 
tion (MI) after hospital dismissal in 
group B patients (shown with 95% 
confidence intervals [vertical bars]), 
with the expected curves by age 
group. In each age group, the event- 
free survival rate was lower than 
expected on the basis of risk factors 
derived from analysis of group A. 
nearly 60%, from 3.3% to 1.4%, and the emergency oronary 
bypass rate decreased nearly 90%, from 5.5% to 0.65%. 
We also found that the elderly population undergoing 
coronary angioplasty at our institution has changed in recent 
years. Since 1990, the average age of these older patients has 
increased; they have a higher incidence of previous myocardial 
infarction and previous bypass urgery; and they have a slightly 
higher index score of concomitant medical diseases. 
This change in the patient population appears to partly 
explain the lack of improvement in the longer term event-free 
survival rates. For example, rates of posthospital survival free 
of myocardial infarction have been slightly higher in recent 
years. The differences inthese vent rates are less marked after 
adjustment with a risk regression equation, but they remain 
significant. No statistical modeling approach of this type 
corrects for all variables, and several baseline variables, uch as 
previous coronary bypass operation, previous myocardial in- 
farction and diabetes mellitus, although not incorporated into 
our model for group A, were univariate predictors of adverse 
outcome in both groups and were more frequent in group B 
than in group A. 
Another possible xplanation for the lack of improvement 
in intermediate-term survival is that a greater number of 
sicker, older patients now survive coronary angioplasty. These 
patients might be expected to have a greater number of late 
events. Thus, the improved initial success rate may change the 
population of hospital survivors into a sicker group of patients 
compared with previous years, when very ill patients had a 
higher in-hospital mortality rate. The higher initial success rate 
also tends to encourage the use of the procedure inhigher isk 
patients than in the past. A trend toward use of coronary 
angioplasty in higher isk patients appears to be supported by 
our data. 
Another conceivable xplanation for the lack of improve- 
ment in long-term event-free survival is a change in the 
strategy of angioplasty. In sick elderly patients, physicians 
often choose to perform culprit vessel coronary angioplasty or 
to limit the dilation procedure to the most critical stenoses 
despite the presence of other significant disease. This decision 
could change the late results, because less complete revascu- 
larization would be expected to lead to more intermediate- 
term ischemic events. However, the difference in the number 
of coronary segments dilated in our two study groups or in the 
rates of complete revascularization was not statistically signif- 
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Figure 3. Comparison of observed 
Kaplan-Meier curves for survival 
free of myocardial infarction (MI) 
after hospital dismissal in group B 
patients (shown with 95% confi- 
dence intervals [vertical bars]), 
with the expected curves by risk 
quintiles. In each risk quintile, the 
event-free survival rate in group B 
was lower than expected on the 
basis of risk factors derived from 
analysis of group A. 
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Figure 4. Comparison of the ob- 
served Kaplan-Meier curves for sur- 
vival free of myocardial infarction, 
coronary artery bypass operation, re- 
peat percutaneous transluminal cor- 
onary angioplasty orsevere angina in 
group B patients (shown with 95% 
confidence intervals [vertical bars]), 
with the expected curves by age 
group. For each age group, the 
event-free survival rate was lower 
than expected on the basis of risk 
factors derived from analysis of 
group A. 
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icant. Furthermore, less aggressive use of coronary angioplasty 
does not seem to have been a trend in group B, despite an 
increase in the average age of the patients. Whether more 
aggressive use of coronary angioplasty would improve the 
overall results in this or other cohorts cannot be determined 
from the current study. The present study also has the other 
limitations that are inherent o retrospective analysis. Because 
a number of treatment techniques and some characteristics of
the patients changed between the two periods, it is ditficult to 
be certain which features are most important to the observed 
changes in outcome. 
Conclusions. The present study demonstrated that the 
technical success rate is substantially higher and acute com- 
plication rates substantially lower for coronary angioplasty 
performed in elderly patients ince 1990 despite an increase 
in patient age and extent of coronary artery disease com- 
pared with earlier years. However, these findings have not 
translated into better intermediate-term event-free survival 
rates possibly because of important changes in patient 
characteristics. 
Appendix 1 
Expected Probability of Events 
Equation for probability of adverse in-hospital events: 
exp(a + btxl + b2x2'' ") 
p (probability ofevent) = 
1 + exp(a + blX ~ + b2x 2 ...)" 
Procedure-related acute myocardial infarction and death: 
Logit(p) = - 8.38 + 0.42 × (no. of 70% lesions) + 0.063 x Age (years). 
Cumulative adverse in-hospital events: 
Logit(p) = - 1.92 + 0.20 × (no. of 70% lesions). 
Figure 5. Comparison of the ob- 
served Kaplan-Meier curves for sur- 
vival free of myocardial infarction, 
coronary artery bypass operation, re- 
peat percutaneous transluminal cor- 
onary angioplasty orsevere angina in 
group B patients (shown with 95% 
confidence intervals [vertical bars]), 
with the expected curves by risk 
quintiles. The event-free survival 
rate tended to be lower than ex- 
pected on the basis of risk factors 
derived from analysis of group A. 
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Appendix 2 
Calculations for Expected Event-Free Curves and 
Relative Risk Ratio 
Equation for proportional hazards model risk for events after hospital 
dismissal: 
,~ (hazard for individual) 
A o (underlying hazard) = exp(blxl + b2x2). 
Late death/myocardial infarction: 
Variable Chi-Square Beta 
No. of 70% lesions 14.4 0.28 
Congestive heart failure 14.3 0.98 
No. of concomitant diseases 27.2 0.44 
Composite--late adverse events: 
Variable Chi-Square Beta 
No. of 70% lesions 25.7 0.21 
Unstable angina 4.7 0.29 
No. of concomitant diseases 21.9 0.23 
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